Loading...
Loading...
CDC PLACES (2023, crude) estimates 15.4% of adults in Rockford have diagnosed diabetes — 3.4 points above the U.S. 12% figure. Census population 148,655. Illinois Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Rockford clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Rockford storefront.
Biodynamic Hematogel Wound Care in Rockford, IL for clinics & physicians. Biodynamic hematogel achieves 96… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 15.4% of adults in Rockford have diagnosed diabetes — 3.4 points above the U.S. 12% figure. Obesity 44.7%; arthritis 28.9%. Those three PLACES crude rates (plus Census 148,655) are the local facts on this page. Everything else is the national biodynamic hematogel catalog and J6 paperwork.
National Biodynamic Hematogel Wound Care notes (how the product actually works)14% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 148,655 residents will still mix those payers. CDC PLACES (2023, crude) estimates 15.4% of adults in Rockford have diagnosed diabetes — 3.4 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Rockford trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 15.4% of adults in Rockford have diagnosed diabetes — 3.4 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 15.4% of adults — 3.4 points above the U.S. 12% figure. Obesity is 44.7%; arthritis is 28.9%. That is place-level BRFSS modeling, not a clinic census and not a Rockford trial.
Illinois is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. National Government Services (NGS) LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Illinois compliance risk.
Bring specialty, monthly wound volume, and whether you bill J6 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 15.4% diabetes and 28.9% arthritis for Rockford — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Rockford, IL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Rockford is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Rockford — 3.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Illinois Part B wound biologics follow this contractor (siblings: MN, WI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Rockford. Useful for joint-program math; still needs a diagnosis and privileging.
No Rockford storefront. Joe Bradley is an active practice owner. biodynamic hematogel stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.